Swiss National Bank - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 265 filers reported holding MYRIAD GENETICS INC in Q4 2018. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,875,972
-30.1%
179,300
+1.0%
0.00%
-33.3%
Q2 2023$4,114,450
+1.3%
177,500
+1.5%
0.00%0.0%
Q1 2023$4,062,927
+43.8%
174,900
-10.2%
0.00%
+50.0%
Q4 2022$2,825,097
-22.3%
194,700
+2.2%
0.00%
-33.3%
Q3 2022$3,635,000
+6.0%
190,500
+0.9%
0.00%
+50.0%
Q2 2022$3,430,000
-27.9%
188,8000.0%0.00%
-33.3%
Q1 2022$4,758,000
+0.4%
188,800
+10.0%
0.00%0.0%
Q4 2021$4,739,000
-13.8%
171,700
+0.9%
0.00%0.0%
Q3 2021$5,496,000
+8.4%
170,200
+2.7%
0.00%0.0%
Q2 2021$5,070,000
-3.1%
165,800
-3.5%
0.00%0.0%
Q1 2021$5,231,000
+56.5%
171,800
+1.7%
0.00%
+50.0%
Q4 2020$3,342,000
+51.6%
169,0000.0%0.00%0.0%
Q3 2020$2,204,000
+16.8%
169,000
+1.6%
0.00%0.0%
Q2 2020$1,887,000
-8.6%
166,400
+15.3%
0.00%0.0%
Q1 2020$2,065,000
-46.4%
144,300
+2.1%
0.00%
-50.0%
Q4 2019$3,850,000
-2.4%
141,400
+2.6%
0.00%0.0%
Q3 2019$3,945,000
+4.2%
137,800
+1.1%
0.00%0.0%
Q2 2019$3,786,000
-16.3%
136,3000.0%0.00%
-20.0%
Q1 2019$4,525,000
+24.1%
136,300
+8.7%
0.01%0.0%
Q4 2018$3,645,000
-34.8%
125,400
+3.1%
0.01%
-16.7%
Q3 2018$5,594,000
+23.1%
121,6000.0%0.01%
+20.0%
Q2 2018$4,544,000
+29.8%
121,600
+2.6%
0.01%
+25.0%
Q1 2018$3,502,000
-14.0%
118,5000.0%0.00%0.0%
Q4 2017$4,070,000
-1.8%
118,500
+3.4%
0.00%
-20.0%
Q3 2017$4,146,000
+40.0%
114,6000.0%0.01%
+25.0%
Q2 2017$2,961,000
+34.6%
114,6000.0%0.00%
+33.3%
Q1 2017$2,200,000
+15.2%
114,6000.0%0.00%0.0%
Q4 2016$1,910,000
-19.0%
114,6000.0%0.00%
-25.0%
Q3 2016$2,358,000
-35.8%
114,600
-4.6%
0.00%
-33.3%
Q2 2016$3,675,000
-13.6%
120,100
+2.1%
0.01%
-25.0%
Q1 2016$4,252,000
+4.2%
117,600
+24.4%
0.01%
-20.0%
Q4 2015$4,079,000
+15.2%
94,5000.0%0.01%
+11.1%
Q3 2015$3,542,000
+23.5%
94,500
+12.0%
0.01%
+28.6%
Q2 2015$2,869,000
-4.0%
84,4000.0%0.01%
-12.5%
Q1 2015$2,988,000
+5.4%
84,400
+1.4%
0.01%
-27.3%
Q4 2014$2,834,000
-11.7%
83,2000.0%0.01%
-8.3%
Q3 2014$3,209,000
-0.9%
83,2000.0%0.01%0.0%
Q2 2014$3,238,000
+11.2%
83,200
-2.3%
0.01%
+9.1%
Q1 2014$2,913,000
+98.0%
85,200
+21.5%
0.01%
+83.3%
Q4 2013$1,471,000
-9.5%
70,100
+1.3%
0.01%
-14.3%
Q3 2013$1,626,000
-17.8%
69,200
-6.0%
0.01%
-22.2%
Q2 2013$1,978,00073,6000.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 4,000,000$45,360,0002.60%
Tieton Capital Management, LLC 166,441$1,887,0002.36%
S&T BANK/PA 315,835$3,582,0000.82%
DISCIPLINED GROWTH INVESTORS INC /MN 2,194,204$24,882,0000.60%
XTX MARKETS LLC 14,807$168,0000.57%
Glenview Capital Management 1,810,727$20,534,0000.57%
EARNEST PARTNERS LLC 4,761,082$53,991,0000.51%
AIMZ Investment Advisors, LLC 42,685$484,0000.31%
DUALITY ADVISERS, LP 163,717$1,857,0000.17%
Engineers Gate Manager LP 219,922$2,494,0000.13%
View complete list of MYRIAD GENETICS INC shareholders